Drug Safety

Risk Management of Medicines and Compensation for Harm
pp. 87-90(4)
Author: Edwards, I. Ralph

A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge
pp. 91-98(8)
Authors: Aronson, Jeffrey K.; Price, Deirdre; Ferner, Robin E.

Defining `Signal' and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions
pp. 99-110(12)
Authors: Hauben, Manfred; Aronson, Jeffrey K.

Treating Hypertension in Older Adults: Safety Considerations
pp. 111-118(8)
Author: Aronow, Wilbert S.

A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
pp. 119-135(17)
Authors: Cahill, Kate; Stead, Lindsay; Lancaster, Tim

Drug-versus-Drug Adverse Event Rate Comparisons: A Pilot Study Based on Data from the US FDA Adverse Event Reporting System
pp. 137-146(10)
Authors: Hochberg, Alan M.; Pearson, Ronald K.; O'Hara, Donald J.; Reisinger, Stephanie J.

Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use: A Systematic Review and Meta-Analysis from the Research on Adverse Drug events And Reports (RADAR) Project
pp. 147-158(12)
Authors: McKoy, June M.; Bennett, Charles L.; Scheetz, Marc H.; Differding, Virginia; Chandler, Kevin L.; Scarsi, Kimberly K.; Yarnold, Paul R.; Sutton, Sarah; Palella, Frank; Johnson, Stuart; Obadina, Eniola; Raisch, Dennis W.; Parada, Jorge P.

Effect of Macrolide and Fluoroquinolone Antibacterials on the Risk of Ventricular Arrhythmia and Cardiac Arrest: An Observational Study in Italy Using Case-Control, Case-Crossover and Case-Time-Control Designs
pp. 159-167(9)
Authors: Zambon, Antonella; >Hernan Polo Friz,; Contiero, Paolo; Corrao, Giovanni

Examining the Tolerability of the Non-Sedating Antihistamine Desloratadine: A Prescription-Event Monitoring Study in England
pp. 169-179(11)
Authors: Layton, Deborah; Wilton, Lynda; Shakir, Saad A.W.